#13M Science. TM Applied to Life." Delivering Performance, Driven by Purpose >Creating value through spin off of Health Care business ➤ Taking action to efficiently and equitably resolve Combat Arms Earplugs Version 2 litigation related to Aearo Technologies LLC ► Delivering in a challenging environment and updating full-year outlook Mike Roman Chairman of the Board & Chief Executive Officer Monish Patolawala Executive Vice President, Chief Financial & Transformation Officer 17 Kevin Rhodes Executive Vice President, Chief Legal Affairs Officer Bruce Jermeland Senior Vice President, Investor Relations#2Forward looking statement This presentation contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2021, as updated by the Company's Current Report on Form 8-K dated April 26, 2022, and any subsequent quarterly reports on Form 10-Q (the "Reports"); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity improvements than estimated; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the proposed spin-off of the Company's Health Care business, including whether the transaction will be completed, or if completed, will be on the expected terms; the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; the ability to satisfy the various closing conditions; potential business disruption; the diversion of management time; the impact of the transaction (or its pendency) on the Company's ability to retain talent; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment (including whether an Internal Revenue Service private letter ruling will be sought or obtained); the risk that any consents or approvals required will not be obtained; risks associated with financings that may be undertaken and indebtedness that may be incurred in connection with the transaction; and (16) matters relating to the voluntary chapter 11 proceedings of the Company's subsidiary Aearo Technologies and certain of its affiliates (the "Aearo Entities"), including legal risks related to the chapter 11 proceedings; potential impacts to the Company's reputation and its relationships with customers, suppliers, employees, regulators and other counterparties and community members; potential impacts to the Company's liquidity or results of operations, including risks related to the amount that will be necessary to fully and finally resolve all of the Company's obligations to make payments to resolve such claims under the terms of its funding and indemnification agreement with the Aearo Entities; and the Aearo Entities' ability to navigate the chapter 11 proceedings to obtain approval and consummation of a plan of reorganization. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments. Note on non-GAAP financial measures This presentation refers to certain non-GAAP financial measures. Refer to 3M's July 26, 2022, press release for descriptions of non-GAAP financial measures such as free cash flow, adjusted free cash flow, free cash flow conversion, adjusted free cash flow conversion, net debt, adjusted EBITDA, and various measures that adjust for the impacts of special items. Refer also to the appendix of this slide deck for descriptions of non-GAAP measures associated with "New 3M" and certain items specific to the Health Care business segment. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in those locations. 3M 2022 Q2 Earnings - July 26, 2022. All rights reserved. 2#33M is taking significant actions to benefit stakeholders Creating value through spin off of Health Care Taking action to resolve Combat Arms Earplugs litigation Delivering in a challenging environment ● 2022 Q2 Earnings - July 26, 2022. All rights reserved. ● ● "New 3M" (1) will remain a leading global material science innovator serving customers in a wide range of end markets Health Care will be a leading global diversified health technology company Each company will be well-capitalized, more agile and focused, and better positioned for long-term success Aearo Technologies and related entities subsidiaries of 3M - have initiated chapter 11 proceedings to resolve current and future Combat Arms Earplugs Version 2 litigation Intended to facilitate an efficient and equitable resolution of litigation (1) "New 3M" defined as 3M pro forma for the spin-off of Health Care. - Sales of $8.7 billion with organic sales growth of one percent year-on-year which included a four percentage point headwind from the combined impact of China COVID-related lockdowns and decline in disposable respirator demand Adjusted earnings per share of $2.48 in midst of continued uncertain macroeconomic and inflationary environment Updating full-year outlook to reflect U.S. dollar strength and macroeconomic environment: organic growth 1.5-3.5% and adjusted EPS $10.30-$10.80 3M 3#4Capitalizing on global megatrends • Expanding demand for innovation in electronics Increasing focus on safety • Advancing automotive technology/mobility solutions ● Accelerating opportunities in growing markets ● Expanding opportunities in digitization Growing interest in home improvement Greater customer emphasis on sustainability 2022 Q2 Earnings - July 26, 2022. All rights reserved. 3M ● Aging global population with expanding access to care Growing demand for virtual and in-home care • Focus on reducing rehospitalizations through infection prevention Healthcare IT system advances and workflow efficiency demands ● ● ● Increasing need for solutions that enhance care delivery and improve patient outcomes ● Better patient care at lower cost Data, analytics, and technologies for delivery of precision medicine 4#5Driving long-term value for shareholders ● ● ● Creates value by launching two industry-leading, well-capitalized, public companies focused on growth, innovation and shareholder returns New 3M remains a leading global materials science innovator positioned to win in attractive end markets Health Care will be a leading global diversified health technology company Enables tailored capital allocation and investments to drive innovation and growth Enhances strategic flexibility Offers distinct and compelling investment profiles appealing to different investor bases Reduces uncertainty by taking action to efficiently and equitably resolve Combat Arms Earplugs litigation 2022 Q2 Earnings - July 26, 2022. All rights reserved. 3M LO 5#62022 Q2 Earnings - July 26, 2022. All rights reserved. 3M Creating value through spin off of Health Care business 6#7Unlocking and unleashing innovation and value creation New 3M Applying science to improve lives Consumer 20% Transportation & Electronics 35% -$26.8B Sales (2021) Adj. Ol (2021) $5.8B 2022 Q2 Earnings - July 26, 2022. All rights reserved. Safety & Industrial 45% Adj. Ol% (2021) 21.7% 3M Health Care Enabling better, smarter, safer healthcare Food Safety 4% Separation and Purification Sciences 11% Health Information Systems 14% Oral Care 17% ~$8.6B Sales (2021) Includes Food Safety (~$0.4B), expected to be divested by Sept. 1, 2022, that will no longer be part of Health Care OI (2021) $2.0B Medical Solutions 54% 01% (2021) 23.7% 7#8Accelerating megatrends favor 3M science and innovation ● ● Proven operating model powered by leading science and technology, manufacturing, global capabilities, and iconic brands Unique and differentiated technologies shared across the organization to better deliver world class customer-driven innovation Continued focus on active portfolio management Strong balance sheet and free cash flow to continue to invest in growth markets and return capital to shareholders 2022 Q2 Earnings - July 26, 2022. All rights reserved. 3M Select Growth Opportunities Auto/Mobility Digitization Wellbeing Electronics Robotics and Automation Safety Sustainability E-commerce Home improvement 8#93M core strengths drive innovative customer solutions Operations ● ● ● Innovation Customer-focused innovation guides investments and R&D Data-driven insights create opportunities and value E-commerce and digital marketplace accelerate customer connectivity 2022 Q2 Earnings - July 26, 2022. All rights reserved. Talent Attract and engage talent with diverse backgrounds, skills, and experience Empower our people through technology and flexibility Continue building on a strong culture of customer-inspired innovation 3M ● ● ● 3M 3M 3M Power end-to-end operations through increased digitization Capitalize on IP-driven manufacturing expertise Enhance customer servi Streamline operating model 9#10Enabling better, smarter, safer healthcare ***** Patient outcomes improving through greater focus on infection prevention, and reducing rehospitalization 2022 Q2 Earnings - July 26, 2022. All rights reserved. ADD Hospitals leveraging more healthcare information technology to improve clinical and operational workflows to drive efficiencies 3M Medicines becoming more complex - requiring specialized, tailored solutions Improving patient experiences in oral care. through the combination of material science and digital science 10#11Creating a diversified healthcare technology leader 2021 Sales ~$8.6.B 1 2021 EBITDA ~$2.7B 2021 EBITDA Margin ~31% 1 - Includes Food Safety (~$0.4B), expected to be divested by Sept. 1, 2022, that will no longer be part of Health Care 2022 Q2 Earnings - July 26, 2022. All rights reserved. Health Care Core Strengths: Proven leadership in multiple care pathways Positioning in attractive end-markets Innovation mindset driving improved patient outcomes Collaborative customer relationships Deep global regulatory expertise Operational excellence and strong cash flow Strong sales growth and profitability with significant recurring sales ● ● ● ● 3M 11#12Well-positioned in growing healthcare markets Medical Solutions 3M cau Focused on wound healing and reducing preventable complications Selected Key Opportunities Wound care $20B+ segment '24E 6-8% growth 2022 Q2 Earnings - July 26, 2022. All rights reserved. Oral Care Long history of commercializing award-winning innovations to improve oral health and aesthetics Dental $10B+ segment '24E 3-5% growth Health Information Systems Clinical insights to support decision-making, reduce administrative burden, and integrate workflows 3M Healthcare IT $40B+ segment '24E 7-14% growth Separation and Purification Sciences Leading supplier of membranes used in development and manufacturing of medical devices, vaccines, and therapeutics Biopharma Filtration $10B+ segment '24E 10-15% growth 12#13Health Care transaction summary Transaction Summary Capitalization Additional Details 2022 Q2 Earnings - July 26, 2022. All rights reserved. • Health Care expected to be spun off with net leverage of 3.0x-3.5x adjusted EBITDA and positioned for rapid deleveraging ● Intended to be a tax-free spin off of Health Care into a standalone publicly-traded company New 3M expected to retain a 19.9% stake in Health Care to be monetized over time ● Subject to final approval by 3M's Board of Directors, effectiveness of Form 10, receipt of IRS ruling, completion of financing, and other customary closing conditions Expected close by year-end 2023 Anticipate no change in 3M's capital allocation priorities through separation 3M 13#142022 Q2 Earnings - July 26, 2022. All rights reserved. 3M Taking action to efficiently and equitably resolve claims 14#15Taking action to efficiently and equitably resolve claims Background Actions Taken Benefits to Stakeholders 2022 Q2 Earnings - July 26, 2022. All rights reserved. ● ● ● ● ● ● ● 3M acquired Aearo Technologies in 2008 and since then it has operated as a wholly-owned subsidiary Claims largely relate to previous generation Combat Arms Earplugs manufactured by Aearo Technologies Approximately 115,000 filed claims, and an additional 120,000 claims on administrative docket, as of June 30, 2022 Aearo Technologies entities have elected to use well-established chapter 11 procedures to resolve all claims determined to be entitled to compensation 3M has committed $1B to fund a trust, based on the analysis of an experienced estimator of claims in chapter 11 3M has also committed an additional $240M to fund projected case related expenses 3M will provide additional funding if required under the terms of the agreement Focuses on achieving an efficient and equitable resolution Reduces uncertainty and increases clarity for all stakeholders Reduces cost and time of litigating thousands of cases 3M 15#16Key Takeaways Creating value through spin off of Health Care business 2022 Q2 Earnings - July 26, 2022. All rights reserved. M CAUTION: Adding dresse C25 20 - ight e pocos Taking action to efficiently and equitably resolve Combat Arms Earplugs litigation 3M CARATION Baye m NALGE! 30 Delivering in a challenging environment, updating full-year outlook 16#17Creating value and delivering for customers Delivered solid Q2 results while focusing on customers and managing supply chain, inflation, geopolitical and COVID dynamics ● — I Overall demand remains strong across most end-markets Navigating inflationary pressures through disciplined price actions Significant Q2 challenges in Greater China region due to COVID lockdowns; stronger than expected improvement in June; expect full recovery through the remainder of the year Strong U.S. dollar resulted in FX sales translation headwind of ~4% year-on-year THI IIII 111111111 Managing impact of Russia/Ukraine conflict 1111111 201 Announced additional investments to resolve matters in Zwijndrecht, restarted manufacturing operations ... ramp up progressing as per plan pdating full-year outlook to Updating full-year environment outlook to reflect U.S. dollar strength and current macroeconomic • Confident in our long-term ability to grow above the macro, drive consistent improvement in margins and strong cash flow 2022 Q2 Earnings - July 26, 2022. All rights reserved. 3M Q2 2022 Organic growth +1.0% Includes (~4 ppt) headwind from combined impact of China lockdowns and disposable respirator decline Adjusted operating margin 21.0% Adjusted earnings per share $2.48 17#18Q2 2022 operating margin and EPS Adjusted Adjusted earnings operating margin per share 23.4% $2.75 + $0.12 - $0.09 -$0.11 - $0.12 Q2 2021 Total organic growth/ productivity/other Disposable respirator China lockdowns Brazil social tax Remaining organic growth/ productivity/other Raw material FX Other expense/income Adjusted tax rate* Shares outstanding Q2 2022 +0.8% 2022 Q2 Earnings - July 26, 2022. All rights reserved. -0.4% -0.7% -1.0% +2.9% -3.1% -0.1% ΝΑ ΝΑ ΝΑ 21.0% +$0.44 -$0.36 -$0.13 -$0.02 + $0.05 + $0.07 $2.48 Commentary ● ● ● ● ● YoY disposable respirator decline in demand Greater China region impact due to COVID lockdowns Non-repeat of favorable Q2 2021 Brazil Supreme Court social tax ruling Strong pricing, spending discipline and benefits from restructuring actions Manufacturing headwinds from global supply chain challenges, including geopolitical impacts Investments in growth, productivity and sustainability Raw material and logistics cost inflation Net of hedge impact Primarily non-operating pension expense offset by lower net interest expense Q2 2022 adjusted tax rate of 19.8% versus 21.6% in Q2 2021 Average diluted shares down ~3% * The effect of income taxes on items that had specific tax rates are reflected within their respective impacts in the table above. 3M 18#19Q2 2022 cash flow and balance sheet Adjusted free cash flow $1.0B -41% year-on-year Adjusted free cash flow conversion 68% -33 ppts year-on-year Cash returned to shareholders $0.8B -38% year-on-year 2022 Q2 Earnings - July 26, 2022. All rights reserved. Adjusted free cash flow Adjusted free cash flow conversion Capital expenditures Net debt Cash returned to shareholders 3M ● ● ● ● ● ● Q2: $1.0B, down 41% YoY; YTD: $1.7B, down 45% YoY Expect full-year adjusted free cash flow conversion in the range of 90% to 100% Q2: 68%, down 33 ppts YoY; YTD: 57%, down 35 ppts YoY Q2 YoY decline due to working capital; cash impact from capitalization of R&D for U.S. tax purposes, as expected Q2: $384M, flat YoY; YTD: $808M, up 15% YoY Continue to expect full-year capex in the range of $1.7B to $2.0B Q2: $13.3B, up 4% YoY Q2: dividends $848M Q2: share repurchases suspended due to pending Food Safety separation YTD: dividends $1.7B; share repurchases $0.8B 19#20Safety & Industrial 2022 Q2 Earnings - July 26, 2022. All rights reserved. Business Group performance REFE Transportation & Electronics 3M Health Care Consumer 20#21Business Group performance Organic growth Q2 2022 Safety & Industrial Transportation & Electronics Health Care Consumer Adjusted operating margin 0.7% 21.5% 0.5% 21.0% 4.4% 22.7% -2.5% 18.5% Commentary Organic growth led by abrasives, electrical markets, closure and masking systems, roofing granules, automotive aftermarket, and industrial adhesives and tapes; personal safety declined Disposable respirator sales declined approximately $150M, or 36% organically YoY; reduced segment organic growth by 5.7 ppts Adjusted operating margins -2.1 ppts YoY; impacted by China lockdowns and manufacturing productivity headwinds; partially offset by strong spending discipline and restructuring benefits ● ● ● ● ● ● ● ● 2022 Q2 Earnings - July 26, 2022. All rights reserved. Organic growth led by advanced materials and commercial solutions; automotive OEM up low-single digits, while transportation safety and electronics declined Semiconductor supply chain challenges continued to impact global auto builds and electronics end-markets Operating margins -0.8 ppts YoY; impacted by manufacturing productivity headwinds due to China lockdowns and shutdown of certain operations in Belgium facility; partially offset by strong spending discipline and restructuring benefits Organic growth led by separation and purification sciences, health information systems, medical solutions, and oral care; food safety was flat Operating margins -2.6 ppts YoY; impacted by manufacturing productivity headwinds and investments; partially offset by sales growth, strong spending discipline, and restructuring benefits U.S. elective medical procedure and oral care volumes were approximately 90 to 95 percent of pre-COVID levels, up sequentially from Q1 levels Organic sales grew in both stationery and office and home care; home improvement and consumer health and safety both declined due to strong prior year comparisons Operating margins -2.2 ppts YoY; impacted by manufacturing productivity headwinds, partially offset by strong spending discipline and restructuring benefits 3M 21#222022 Q2 Earnings - July 26, 2022. All rights reserved. wwww MVIWAN 2022 outlook 3M C 22#23Updating estimates to reflect FX and macroeconomic environment Adjusted earnings per share $10.30 to $10.80 Adjusted free cash flow conversion 90% to 100% Updating full-year expectations: Organic sales growth 1.5% to 3.5% 1 FX impact on total sales growth: • -4% vs. -1% previously U.S. dollar at a 20-year high ● 2 Organic sales growth: ● 1.5% to 3.5% vs. 2% to 5% previously Ongoing macroeconomic uncertainty Macro: IPI & GDP: ~3%; most end-markets remain strong Monitoring Greater China region COVID-related lockdowns Geopolitical uncertainty due to Russia/Ukraine conflict ● End-markets/supply chain/inflationary impacts: • Auto OEM builds up ~5% YoY; semiconductor and supply chain challenges along with geopolitical impacts constraining pace of build rate U.S. healthcare elective procedure volumes ~95% to 100%; U.S. oral care volumes at ~90% by year-end, impacted by COVID-related staff shortages and patient cancellations Weakening consumer electronics demand, particularly smartphones, tablets and TVs Monitoring consumer sentiment and spending trends Expecting supply chain challenges to persist for foreseeable future Navigating inflationary pressures through disciplined price actions; expect raw material & logistics full-year headwind of $750M to $850M YOY Note: Above guidance does not include the impact of pending separation of Food Safety business via Reverse Morris Trust (RMT) transaction with Neogen 2022 Q2 Earnings - July 26, 2022. All rights reserved. 3M 23#24Q&A Mike Roman Chairman of the Board & Chief Executive Officer 2022 Q2 Earnings - July 26, 2022. All rights reserved. Monish Patolawala Executive Vice President, Chief Financial & Transformation Officer 3M Kevin Rhodes Executive Vice President, Chief Legal Affairs Officer Bruce Jermeland Senior Vice President, Investor Relations 24#252022 Q2 Earnings - July 26, 2022. All rights reserved. Appendix 3M 25#26Q2 2022 P&L ($M) Sales Gross profit % to sales SG&A % to sales R&D & related % to sales Operating income % to sales Net income GAAP earnings per share 2022 Q2 Earnings - July 26, 2022. All rights reserved. Q2 2022 $8,702 $3,609 41.5% $3,023 34.7% $476 5.5% $110 1.3% $78 $0.14 Q2 2021 $8,950 $4,231 47.3% $1,746 19.6% $514 5.7% $1,971 22.0% $1,524 $2.59 Change -2.8% -14.7% -5.8 pts +73.2% +15.1 pts -7.4% -0.2 pts -94.4% -20.7 pts -94.9% -94.7% 3M 26#27Q2 2022 sales recap Americas +3.9% Organic growth Acquisitions/divestitures FX Total growth Organic growth 2022 Q2 Earnings - July 26, 2022. All rights reserved. -0.2% +3.7% U.S. +2% EMEA -2.0% -% -10.2% -12.2% APAC -1.8% -% -6.0% -7.8% Canada Mexico +17% +13% 3M Worldwide +1.0% -% -3.8% -2.8% Brazil +9% China/HK -8% Japan +1% 27#28Business segment information ($M) Business groups Safety & Industrial Transportation & Electronics Health Care Consumer Total Operating Business Segment Corporate & Unallocated Total Q2 2022 $2,924 Net Sales $2,268 $2,179 $1 Q2 2021 $3,029 $2,355 $1,330 $1,400 2022 Q2 Earnings - July 26, 2022. All rights reserved. $2,165 $1 $8,702 $8,950 Organic growth 0.7% 0.5% 4.4% -2.5% 1.0% Q2 2022 Sales Growth FX -4.1% -4.2% -3.8% -2.5% -3.8% M&A % Total Sales Change -3.4% 3M -3.7% 0.6% -5.0% -2.8% Adjusted Operating Income* Q2 2022 $630 $476 $494 $247 $1,847 $(21) $1,826 Q2 2021 $714 $513 $548 $290 $2,065 $33 $2,098 Percent change -11.8% -7.5% -9.9% -14.9% *"Safety & Industrial", "Corporate & Unallocated", "Total Operating Business Segment" and "Total" provided on an adjusted basis Organic growth = organic volume + price -13.0% Adjusted Operating Margin* Q2 2022 21.5% 21.0% 22.7% 18.5% 21.0% Q2 2021 23.6% 21.8% 25.3% 20.7% 23.4% 28#29Additional sales detail ($M) Business groups Abrasives Automotive Aftermarket Closure and Masking Systems Electrical Materials Industrial Adhesives & Tapes Personal Safety Roofing Granules Other Safety & Industrial Total Safety & Industrial Business Group Advanced Materials Automotive & Aerospace Commercial Solutions Electronics Transportation Safety Other Transportation & Electronics Total Transportation & Electronics Business Group 2022 Q2 Earnings - July 26, 2022. All rights reserved. Net Sales Q2 2022 346 289 270 336 586 972 125 2,924 307 428 448 863 222 2,268 Q2 2021 326 294 254 313 599 1,125 121 (3) 3,029 302 443 441 913 257 (1) 2,355 3M ($M) Business groups Food Safety Health Information Systems Medical Solutions Oral Care Separation & Purification Sciences Other Health Care Total Health Care Business Group Consumer Health & Safety Home Care Home Improvement Stationery & Office Other Consumer Total Consumer Business Group Corporate & Unallocated Total 3M Net Sales Q2 2022 89 309 1,169 357 255 2,179 145 261 582 342 1,330 1 8,702 Q2 2021 94 299 1,166 363 247 (4) 2,165 157 268 645 332 (2) 1,400 1 8,950 29#30Certain non-GAAP measures Refer also to 3M's July 26, 2022 press release for descriptions of other non-GAAP financial measures and reconciliations to their most directly comparable GAAP financial measures. Year ended December 31, 2021 (dollars in millions) Net sales Safety & Industrial Transportation & Electronics Consumer Health Care Corporate and Unallocated Total net sales Business segment operating income (measure of segment operating performance) Operating income margin Adjustments for special items: net costs for significant litigation Adjusted operating income (non-GAAP measure) Adjusted operating income margin (non-GAAP measure) Depreciation and amortization expense Business segment EBITDA (non-GAAP measure)b 6A - [A] 3M Company 11,981 $ 9,262 5,513 8,597 2 35,355 $ 7,369 $ 463 [B] Health Care 8,597 8,597 2,037 $ 23.7% N/A 636 2,673 31.1 % A A New 3M (non-GAAP measures)a Amount [A-B] % of sales 11,981 9,262 5,513 2 26,758 5,332 463 5,795 21.7% 45% 35% 20% 100% Business segment EBITDA margin (non-GAAP measure)b (a) Certain amounts New 3M (net sales, adjusted operating income, adjusted operating income margin, and percentages of business segment net sales) are non-GAAP measures, are not defined under U.S. GAAP and, therefore, should not be considered a substitute for other measures prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. 3M defines these items as the respective consolidated 3M Company amounts minus those of (or calculated without) its Health Care business segment. 3M has announced it will spin off the Health Care business. Amounts described as "adjusted" are adjusted for the impacts of special items. Special items for the periods presented include the items described in the section entitled "Description of Special Items". The Company believes that Certain amounts New 3M information is meaningful to investors as they consider how the spin off of the Health Care business may impact 3M's operating results. (b) Business segment EBITDA and EBITDA margin are not defined under U.S. GAAP. Therefore, they should not be considered a substitute for other measures prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. For business segments, the Company defines EBITDA as business segment operating income (3M's measure of segment operating performance) adjusted for depreciation and amortization expense. The Company defines EBITDA margin as EBITDA divided by net sales. The Company considers these non- GAAP measures in evaluating and managing the Company's operations. The Company believes EBITDA and EBITDA margin are meaningful to investors as they provide useful analyses of ongoing underlying operating trends. 3M 2022 Q2 Earnings - July 26, 2022. All rights reserved. 30#31Certain non-GAAP measures (continued) Description of Special Items - 2021 In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for 2021 include the items described below: Net costs for significant litigation: • These relate to 3M's respirator mask/asbestos, PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities, external legal fees, and insurance recoveries, along with the associated tax impacts. Net costs related to respirator mask/asbestos and Combat Arms Earplugs matters are reflected as special items in the Safety and Industrial business segment while those associated with PFAS-related other environmental matters are primarily reflected as corporate special items in Corporate and Unallocated. 2022 Q2 Earnings - July 26, 2022. All rights reserved. 3M 31#323M Science. TM Applied to Life.™M